Accelerating Nanotech Innovations Through a Safer-By-Design Approach, Safer Nanomaterials School
14 May 2019 | Contributor(s): Philippe Sabatier
Nano WG May 9, 2019European Scientific Institute (ESI) Safer Nanomaterials School Introduction.
Development of Targeted Nanomedicines via Machine Learning Processes
05 Mar 2019 | Contributor(s): Daniel Heller
Nano WG February 21, 2019Description: We are using data science to facilitate the development of nanoparticle drugs incorporating kinase inhibitors with diverse chemical structures. Doing this work inspired us to bring together the nanoinformatics community...
Development of natural language processing tools for nanoparticle design
05 Mar 2019 | Contributor(s): Nastassja Lewinski
Nano WG February 28, 2019: In this presentation, an introduction to the application of natural language processing techniques to nanotechnology data will be discussed. Natural language processing tools can aid in the automatic categorization, extraction, and analysis of data from...
NCI Alliance for Nanotechnology in Cancer, and caNanoLab: A Data Repository for Cancer Nanomedicines
27 Nov 2018 | Contributor(s): Luisa Russell, Mervi Heiskanen
Nano WG presentation November15, 2018 NCI Alliance for Nanotechnology in Cancer –Structure–Achievements–Scientific FocuscaNanoLab–Intro to Platform–Data Curation–User Statistics–Future Directions
NCIP Hub: Collaboration Tool for NCI Affiliated Programs and Investigators
16 Nov 2018 | Contributor(s): Mervi Heiskanen, Aparna Vinodh
NCIP Hub overview and CRCHD PACHE Hub demonstration.
Integrative Cancer Biology Program Datasets
26 Apr 2016 | Series | Contributor(s): Jonathan Bistline, Michael Reich
The NCI-ICBP promotes an integrative/systems approach to the study of cancer biology. The Program encourages scientists to study cancer as a complex biological system. Information gained from these studies are used to build reliable and testable predictive computation models of cancer processes...
Breast Cancer Crossword
20 Nov 2015 | Teaching Materials | Contributor(s): Katelyn Schifano
This crossword is designed for use in social media as well as patient waiting areas.
Screening for Small Molecules: Target Discovery Against miRNAs for Breast Cancer Treatment
18 Aug 2015 | Presentations | Contributor(s): Odemaris Narvaez del Pilar
Breast cancer is one of the leading causes of cancer related deaths and morbidity among women worldwide. Identifying new targets and developing new therapies is very important in order to improve patient outcomes and minimize this health burden. MicroRNAs, a type of non-coding RNA, are potential...
Report to the DICOM Standards Committee - December 4, 2015
10 Dec 2014 | Downloads | Contributor(s): Joseph Kalen
LBL ICBP50 integrative genomic data
13 Nov 2014 | Downloads | Contributor(s): Joe Gray, Jonathan Bistline
From Joe Gray, Lawrence Berkeley National Laboratory. There are seventeen (17) files in this study: Affymetrix U133A gene expression data (icbp_u133a.gct) Affymetrix U133A gene expression data (ICBP_U133a.zip) Affymetrix splice junction exon-exon data (ICBP_Junction.zip) Affymetrix...
Baylor Residual breast cancer
13 Nov 2014 | Downloads | Contributor(s): Creighton C, Lewis M, Chang J, Jonathan Bistline
Residual breast cancers after conventional therapy display mesenchymal as tumor-initiating features. There are four (4) files included in this study: Sample Annotation (combined_sample_annotation.txt) Gene expression data from CD44+/CD24- cells sorted by flow cytometry (GSE7513.gct) Human...
Talking Science: Designing and Delivering Successful Oral Presentations
18 Sep 2014 | Downloads | Contributor(s): Shawn Mullen
Integrated analysis of breast cancer cell lines reveals unique signaling pathways
16 Sep 2014 | Publications | Contributor(s): Laura M Heiser, Nicholas J Wang, Carolyn L Talcott, Keith R Laderoute, Merrill Knapp, Yinghui Guan, Zhi Hu, Safiyyah Ziyad, Barbara L Weber, Sylvie Laquerre, Jeffrey R Jackson, Richard F Wooster, Wen Lin Kuo, Joe W Gray, Paul T Spellman
AbstractBackgroundCancer is a heterogeneous disease resulting from the accumulation of genetic defects that negatively impact control of cell division, motility, adhesion and apoptosis. Deregulation in signaling along the EgfR-MAPK pathway is common in breast cancer, though the manner in which...
"DICOM 301" - Enhanced Multi-frame and Quantitation:
04 Sep 2014 | Presentations | Contributor(s): David Clunie
In-depth presentation on the Digital Imaging and Communications in Medicine StandardA one-hour presentation of DICOM presented by Dr. David Clunie for the members of DICOM Working Group 30, Small Animal Imaging.
pRainBow optical barcoding library
14 Aug 2014 | Reagents | Contributor(s): Andries Zijlstra
Note: this is a work in progress. About: pRainBow is a library of lentiviral vectors designed to allow for fluorescent labeling of cells with one of 7 distinct fluorescent proteins. Composition: How to obtain: How to cite: Other information:Good global...
Cloud Supercomputer Aided Diagnostic Imaging Decision Support System
18 Jun 2014 | Presentations | Contributor(s): Hiro Yoshida
ITCR PI meeting presentation on project status.
Data Acquisition Working Group
21 Apr 2014 | Presentations | Contributor(s): Tom Chenevert, Paul Kinahan
DA-WG Update on PET-CT and DWI MRI
Rationale for Creating an International Forum and NCI Funding Opportunities
18 Apr 2014 | Presentations | Contributor(s): Larry Clarke
The topic here is the creation of research networks and their value to cancer research.The Cancer Imaging Program, is administering several research networks. This presentation on the creation and value of two of them (The Network for Translational research or NTR, and the Quantitative Imaging...
Translational Cancer Imaging
18 Apr 2014 | Presentations | Contributor(s): Tony Ng, David Hawkes, Shonit Punwani
2014 QIN Face to Face Meeting
18 Apr 2014 | Workshops | Contributor(s): Jayashree Kalpathy-Cramer, Laurence Clarke
The Quantitative Imaging Network (QIN) grows from the NCI program announcement "Quantitative Imaging for Evaluation of Responses to Cancer Therapies". The network is designed to promote research and development of quantitative imaging methods for the measurement of tumor response to therapies in...